# Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women

> **NCT00545116** · PHASE2 · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 144 (actual)

## Conditions studied

- Osteopenia
- Osteoporosis

## Interventions

- **OTHER:** Hesperidin

## Key facts

- **NCT ID:** NCT00545116
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2015-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00545116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00545116, "Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT00545116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*